1-methyl-3-isobutylxanthine has been researched along with HIV in 1 studies
1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.
HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bryn, T | 1 |
Mahic, M | 1 |
Aandahl, EM | 1 |
Frøland, SS | 1 |
Aukrust, P | 1 |
Taskén, K | 1 |
1 other study available for 1-methyl-3-isobutylxanthine and HIV
Article | Year |
---|---|
Inhibition of protein kinase A improves effector function of monocytes from HIV-infected patients.
Topics: 1-Methyl-3-isobutylxanthine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cells, C | 2008 |